The President and CEO of Bellerophon (NASDAQ: BLPH) is Buying Shares

By George MacDonald

Today, the President and CEO of Bellerophon (NASDAQ: BLPH), Jonathan Peacock, bought shares of BLPH for $27.35k.

Jonathan Peacock increased his holding by 18.92% to a total of $1.38.

The company has a one year high of $12.92 and a one year low of $2.75. BLPH’s market cap is $63.01M and the company has a P/E ratio of 3.9%. Currently, Bellerophon has an average volume of 69.74k.

One of the top 25 analysts, according to TipRanks.com, recently recommended Buy BLPH with a $19 price target.

Over the last 3 months, the insider sentiment on Bellerophon has been neutral based on 15 corporate insider transactions. This sentiment is slightly lower than the average sector sentiment of insiders.

Bellerophon Therapeutics LLCis a clinical-stage therapeutics company developing products at the intersection of drugs and devices that address unmet medical needs in the treatment of cardiopulmonary and cardiac diseases.